PharmAla Signs Drug Donation Agreement for MDMA-Assisted Therapy Clinical Trial in Fibromyalgia
Globenewswire· 2026-02-26 13:26
TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), announced that it has executed an agreement with Spaulding Rehabilitation (“Spaulding Rehabilitation”), a member of the Mass General Brigham healthcare system, for the provision of MDMA for use in a clinical trial investigating MDMA-assisted therapy for the trea ...
STEALTHGAS INC. Announces the Date for the Release of the Fourth Quarter and Twelve Months 2025 Financial and Operating Results, Conference Call and Webcast
Globenewswire· 2026-02-26 13:24
ATHENS, Greece, Feb. 26, 2026 (GLOBE NEWSWIRE) -- STEALTHGAS INC. (NASDAQ: GASS) (the “Company”), a ship-owning company serving the liquefied petroleum gas (LPG) sector of the international shipping industry, announced today that it will release its fourth quarter operating and financial results for the period ended December 31, 2025 before the market opens in New York on March 2, 2026. On March 2, 2026 at 10:00 am ET, the company’s management will host a conference call to discuss the results and the compa ...
SCYNEXIS Announces First Participants Dosed in a Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of Intravenous SCY-247
Globenewswire· 2026-02-26 13:23
Results from IV Phase 1 SAD/MAD Trial Expected in 2026JERSEY CITY, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that the first participants have been dosed in a Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) trial evaluating the intravenous formulation (IV) of its second-generation triterpenoid antifungal therapy, S ...
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy
Globenewswire· 2026-02-26 13:19
Physician Interview Now AvailableKey Highlights Responder Analysis: 59.4% of patients achieved ≥30% reduction in abdominal pain; 68.1% achieved ≥30% reduction in bloating—using the FDA-recognized responder endpoint consistent with the Company’s peer-reviewed randomized controlled trial.CMS Payment Rate: $300 national Medicare payment rate established, effective January 1, 2026.Physician Perspective: New interview with Gastroenterologist Dr. Dak Patel about inFoods IBS in clinical use now available at https: ...
Inuvo to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on Thursday, March 5th at 4:15 P.M. ET
Globenewswire· 2026-02-26 13:15
LITTLE ROCK, Ark., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leader in artificial intelligence-driven advertising technology, will release its financial results for the fourth quarter and full year ended December 31, 2025, after market close on Thursday, March 5, 2026. The Company will host a conference call at 4:15 p.m. Eastern Time that same day to discuss the results and provide a business update. Conference Call Details: Date: Thursday, March 5, 2026Time: 4:15 p.m. Eastern T ...
Polyrizon Announces Successful Study of its Naloxone Formulation Demonstrating Enhanced Nasal Deposition Profile Versus Commercial Reference Product
Globenewswire· 2026-02-26 13:12
Raanana, Israel, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal administrated solutions, today announced results from a comparative study evaluating the regional nasal deposition profile of its naloxone formulation versus a commercial reference product. The study was conducted at the University of Parma’s Biopharmanet-TEC research center under the scientific supervision of Prof. Fabio Sonvico. T ...
Navigator Gas Announces Date for the Release of Fourth Quarter and Full Year 2025 Results and Zoom Conference Call
Globenewswire· 2026-02-26 13:05
LONDON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Navigator Holdings Ltd. (described herein as “Navigator Gas” or the “Company”) (NYSE: NVGS), the owner and operator of the world’s largest fleet of handysize liquefied gas carriers, announces today that it will release its results for the three and twelve months ended December 31, 2025, after markets close in New York, on Wednesday, March 11, 2026. The next day, Thursday, March 12, 2026, at 9:00 A.M. E.T., the Company’s management team will host a Zoom conference ca ...
Inseego Introduces Next Generation of Inseego Subscribe BSS Solution at Mobile World Congress 2026
Globenewswire· 2026-02-26 13:05
Core Insights - Inseego Corp. has announced the next generation of its cloud-based SaaS BSS platform, Inseego Subscribe, aimed at helping service providers effectively compete for complex enterprise and government customers [1][3] Group 1: Platform Features and Benefits - Inseego Subscribe is designed to help service providers economically manage the lifecycle of complex enterprise and government wireless customers, enabling efficient sales, onboarding, and operations [2][3] - The platform reduces customer acquisition costs, accelerates sales cycles, increases revenue, improves retention, and lowers ongoing support costs for high-value accounts [3][4] - It offers self-service capabilities for enterprise administrators, allowing them to manage governance, compliance, and operational controls without ongoing provider intervention [6] Group 2: Enhancements and Innovations - The updated release features a streamlined user experience with a redesigned UX that simplifies quoting, selling, and managing enterprise services through a CPQ-style interface [7] - Inseego Subscribe digitizes government contract line items, automating complex workflows and enabling service providers to scale SLED and Federal programs more efficiently [8] - A new API layer simplifies integration with carrier environments, reducing the time and effort required for onboarding new service providers [9][10] Group 3: Strategic Positioning - Inseego Subscribe is part of Inseego's evolution into a cloud-first wireless edge platform, combining subscriber lifecycle management with connectivity, security, and network management [12] - The platform is designed to turn enterprise cellular connectivity into a strategic advantage for service providers, enhancing their ability to deliver wireless solutions across various sectors [12] Group 4: Availability and Future Plans - The new version of Inseego Subscribe is set to be available in the second half of the year, with plans to showcase the platform at Mobile World Congress 2026 [13]
StepStone Group to Present at the RBC Capital Markets Global Financial Institutions Conference
Globenewswire· 2026-02-26 13:05
Company Overview - StepStone Group Inc. is a global private markets investment firm that provides customized investment solutions and advisory and data services to clients [2] - As of December 31, 2025, StepStone managed approximately $811 billion in total capital, which includes $220 billion in assets under management [2] - The firm's clients consist of large public and private pension funds, sovereign wealth funds, insurance companies, endowments, foundations, family offices, and high-net-worth individuals [2] Upcoming Events - Scott Hart, CEO, and Mike McCabe, Head of Strategy, are scheduled to present at the RBC Capital Markets Global Financial Institutions Conference on March 10, 2026, at 4:00 pm ET [1] - A live webcast and replay of the presentation will be available on the StepStone website [1]
1847 Holdings Subsidiary CMD Secures Over $4 Million in New Contracts, Expanding Pipeline to $17.4 Million in Anticipated Q1–Q2 Project Awards
Globenewswire· 2026-02-26 13:00
CMD Active bid pipeline exceeds $160 million—the largest in company history—across multifamily, tract home, custom home, and commercial segmentsNEW YORK, NY, Feb. 26, 2026 (GLOBE NEWSWIRE) -- 1847 Holdings LLC (OTC: LBRA) (“1847” or the “Company”), a diversified acquisition holding company focused on identifying and monetizing overlooked, deep-value businesses, today announced that its wholly owned subsidiary, CMD, Inc. (“CMD”), has been awarded over $4 million in new contracts, with an additional pipeline ...